Biotransformation of drugs is essential to facilitate their excretion. For example, lipid-soluble drugs are not easily excreted from the kidney as these are reabsorbed through renal tubules into the blood stream. Drug metabolism aims to convert the drug into a water-soluble form easily excreted from the body. There are two main types of drug biotransformation reactions, namely phase I and phase II reactions. Phase I reactions: These are non-synthetic reactions performed mainly by liver microsomal enzymes called cytochrome P-450 (CYP-450) enzymes. There are many subfamilies, each responsible for the metabolism of certain drug classes, including CYP1A2, CYP2E1, CYP3A4, ..etc. Phase I reactions include oxidation, reduction, hydrolysis, oxidative deamination, sulfoxidation, O-delakylation, N-dealkylation and aromatic hydroxylation. Induction and inhibition of liver microsomal enzymes affect drug pharmacokinetics massively. For example, induction of liver microsomal enzymes reduces the action of potent drugs administered in low doses like anticoagulants and contraceptives. Additionally, drugs converted to toxic forms by liver microsomal enzymes like paracetamol, isoniazid and D-galactosamine, show increased toxicity by microsomal enzyme induction. The reverse is true for liver microsomal enzyme inhibition. Inducers of liver microsomal enzymes include: Acute alcohol ingestion. Drugs like phenobarbital (increases its own metabolism leading to tolerance) and phenytoin (increases codeine metabolism). Diseases like diabetes mellitus. Fasting. Hormones like insulin (stimulates barbiturate metabolism). Alternatively, inhibitors of liver microsomal enzymes include: Chronic alcohol ingestion (inhibits phenobarbital metabolim). Drugs like cimetidine (broad-spectrum inhibitor), dicoumarol (inhibits phenytoin metabolism) and phenylbutazone (inhibits tolbutamide metabolism). Toxic doses of radiation. Diseases like hypothyroidism and neoplastic diseases. Hormones like estrogens and progestins (inhibit mepiridine metabolism). Effect of biotransformation reactions on drug activity and toxicity: 1- A drug may be converted from an active form to an equally active form (e.g. hydrolysis of aspirin to salicylic acid). 2- A drug may be converted from an active form to an inactive form (e.g. hydrolysis of acetylcholine to choline and acetic acid). 3- A drug may be converted from an active form to a toxic form (e.g. oxidation of methanol to formaldehyde). 4- A drug may be converted from an active form to metabolites with different activities (e.g. phenylbutazone is oxidized to two metabolites; one anti- rheumatic and another uricosuric). 5- A drug may be converted from an inactive form to an active form (e.g. reduction of chloral hydrate to trichloroethanol). 6- A toxicant may be converted from an inactive form to a toxic form (e.g. oxidation of parathion to toxic metabolite). Phase II reactions: These are synthetic or conjugation reactions. These always terminate in a safe product that is water-soluble and easily excreatble. Drugs are subjected to phase II reactions directly or after phase I reactions (most cases). In few cases, drugs may be subjected to phase I after phase II reactions. Phase II reactions involve conjugation with water-soluble endogenous molecules as shown in the following table:
No comments:
Post a Comment